Assignment Vinge advises Calliditas in connection with a directed share issue

July 04, 2019

The Board of Directors of Calliditas Therapeutics AB (publ) (“Calliditas”) has resolved on a directed new issue of shares, whereby the company will raise proceeds of approximately SEK 210 million, before issue costs.

The share issue is directed to a number of selected international and Swedish reputable investors and life sciences specialist investors, on the basis of an accelerated bookbuilding process conducted by Carnegie Investment Bank and Zonda Partners.

Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which the company can partially or completely participate in the commercialization efforts. 

Vinge’s team has consisted of Dain Hård Nevonen, Nils Fredrik Dehlin and Edin Agic.

Employment law podcast – our first episode in English

By popular request, here is our very first English-language episode of Vinge's employment law podcast Arbetsrättspodden.
November 28, 2019

Viveka Classon new partner in Stockholm

Viveka Classon has been elected as a new partner at Vinge’s Stockholm office.
November 14, 2019

Maria-Pia Hope wins the Swedish Bar Association’s award for outstanding work within the legal profession

For the eighth year in a row, the Swedish Bar Association has issued the award for outstanding achievements within the legal profession. In 2019, the award goes to Maria-Pia Hope, Managing Partner at Advokatfirman Vinge.
October 25, 2019